/Investor DB

SmartGateVC — 2025 Investments

4 investments dated 2025 · listed companies and verified rows first · show all

Amarosamaros.aiin𝕏Jun 2025

Amaros builds AmarosEngine, a precision intelligence platform that integrates ophthalmology clinics' EHR, practice management, and imaging systems to unify ophthalmic data and generate real-world evidence and insights.

AI & Machine LearningBiotechDigital Health

Ben Toker(President & Co-Founder)in

Coherence Neurocoherenceneuro.comin𝕏Nov 2025 · $10M

Coherence develops neurotechnology systems that measure and modulate brain activity to treat cancer and other neurological diseases.

AI & Machine LearningBiotechMedical DevicesSan Francisco, US

Ben Woodington(Co-founder & CEO)inElise Jenkins(Co-founder & CTO)in

Co-investorsArtesianASDF VenturesBlackbird VenturesDivergent CapitalEmpath VenturesIrregular Expressions+5 more

Cordance Medicalcordancemedical.comin𝕏Nov 2025

Cordance Medical develops medical technology focused on diagnosing and treating patients with brain diseases, drawing on expertise from neurosurgery, neuroimaging, and biomedical engineering.

AI & Machine LearningBiotechDeep TechDigital HealthHealthtechMedical DevicesMountain View, US

Ryan Dittamore(CEO)in

Co-investorsAngel Physicians FundBeresford VenturesBlack Mountain VentuesCreative Destruction Lab (CDL)Samsung NextShanda Group+3 more

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Ladder Bio (formerly ThirdLaw Molecular)

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.